Private demand for cholera vaccines in rural Matlab, Bangladesh

Health Policy

Volumn 85, Issue 2, 2008, Pages 184-195

  Islam, Ziaul ^a   Maskery, Brian ^b   Nyamete, Andrew ^c   Horowitz, Mark S ^b   Yunus, Mohammad ^a   Whittington, Dale ^b  

^a INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c International Vaccine Institute   (South Korea)

Author keywords

Bangladesh; Cholera; Contingent valuation; Vaccine demand; Willingness to pay

Indexed keywords

CHOLERA VACCINE;

ARTICLE; BANGLADESH; CLINICAL TRIAL; CONTINGENT VALUATION; DRUG COST; DRUG EFFICACY; HUMAN; REGRESSION ANALYSIS; RURAL AREA;

ADULT; BANGLADESH; CHOLERA VACCINES; COMMERCE; FEMALE; HEALTH CARE SURVEYS; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PRIVATE SECTOR; VIBRIO CHOLERAE;

EID: 37349117639     PISSN: 01688510     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healthpol.2007.07.009     Document Type: Article

References (24)

1. Glass R.I., and Steele A.D. The value of cholera vaccines reassessed. The Lancet 366 (2005) 7-8
2. Huq A., Sack R.B., Nizam A., Longini I.M., Nair G.B., Ali M., et al. Critical factors influencing the occurrence of Vibrio cholerae in the environment of Bangladesh. Applied and Environmental Microbiology 71 (2005) 4635-4654
3. Ryan E.T., Dhar U., Khan W.A., Salam M.A., Faruque A.S.G., Fuchs G.J., et al. Mortality, morbidity, and microbiology of endemic cholera among hospitalized patients in Dhaka, Bangladesh. American Journal of Tropical Medicine and Hygiene 63 (2000) 12-20
4. Acosta C., Galindo C., Deen J., Ochiai R., Lee H., von Seidlein L., et al. Vaccines against cholera, typhoid fever, and shigellosis for developing countries. Expert Opinion on Biological Therapy 12 (2004) 1939-1951
5. Clemens J.D., Sack D.A., Harris J.R., van Loon F., Chakroborty J., Ahmed F., et al. Field trial of oral cholera vaccines in Bangladesh: results from three-year follow-up. The Lancet 335 (1990) 270-273
6. Ali M., Emch M., von Seidlein L., Yunus M., Sack D.A., Rao M., et al. Herd immunity conferred by killed oral cholera vaccines in Bangladesh: a reanalysis. The Lancet 366 (2005) 44-49
7. Ali M, Emch M, Yunus M, Sack D, Lopez AL, Holmgren J, Clemens J. Vaccination of Adult Women against Cholera Protects Infants and Young Children in Rural Bangladesh. 2007.
8. DeRoeck D., Clemens J.D., Nyamete A., and Mahoney R.T. Policymakers' views regarding the introduction of new-generation vaccines against typhoid fever, shigellosis and cholera in Asia. Vaccine 23 (2005) 2762-2774
9. Whittington D., Matsui O., Frieberger J., Houtven G.V., and Pattanayak S. Private demand for an HIV/AIDS vaccine: evidence from Guadalajara, Mexico. Vaccine (2002) 20
10. Whittington D., Pinheiro A.C., and Cropper M. The economic benefits of malaria prevention: a contingent valuation study in Marracuene, Mozambique. Journal of Health and Population in Developing Countries (2003) 1-27
11. Cropper M.L., Haile M., Lampietti J., Poulos C., and Whittington D. The demand for a malaria vaccine: evidence from Ethiopia. Journal of Development Economics 75 (2004) 303-318
12. Suraratdecha C., Ainsworth M., Tangcharoensathien V., and Whittington D. The private demand for an AIDS vaccine in Thailand. Health Policy and Planning 71 (2005) 271-287
13. Canh D.G., Whittington D., Thoa L.T.K., Utomo N., Hoa N.T., Poulos C., et al. Household demand for typhoid fever vaccines in Hue, Vietnam: implications for immunization programs. Health Policy and Planning 21 (2006) 241-255
14. Hanemann W.M. Valuing the environment through contingent valuation. Journal of Economic Perspectives 8 (1994) 19-43
15. Carson R. Contingent valuation: a user's guide. Environmental Science and Technology 34 (2000) 1413-1418
16. Whittington D. Improving the Performance of contingent valuation studies in developing countries. Environmental and Resource Economics 22 (2002) 323-367
17. International Centre for diarrhoeal disease research Bangladesh: centre for health and population research. Health and demographic surveillance system-Matlab, vol. 36, Registration of health and demographic events 2003 (2005), ICDDR,B, Centre for Health and Population Research, Dhaka
18. Sack D.A. When should cholera vaccine be used in cholera-endemic areas?. Journal of Health, Population, and Nutrition 21 (2003) 299-303
19. International Centre for Diarrhoeal Disease Research Bangladesh. Annual Report, vol. 36: 2004. Dhaka: ICDDR,B; 2005.
20. Immunization and Vaccine Development. Bangladesh EPI Fact Sheet, 2004. World Health Organization; 2005.
21. Levin A., Howlader S., Ram S., Siddiqui S.M., Razul I., and Routh S. Case study on the cost and financing of immunization services in Bangladesh (1999), Partnerships for Health Reform Project, Abt Associates, Inc., Bethesda, MD
22. Maskery B, Islam Z, Deen J, Whittington D. An estimate of the economic value parents in rural Bangladesh place on ex ante risk reductions for their children; 2007 (unpublished).
23. Cook J., Johnson F.R., Nyamete A., Canh D.G., and Whittington D. Reliability of Stated Preferences for Vaccines with Time to Think. Economic Inquiry 45 (2006) 100-114
24. Lucas M.E.S., Jeuland M., Deen J., Lazaro N., MacMahon M., Nyamete A., et al. Private demand for cholera vaccines in Beira, Mozambique. Vaccine 25 (2007) 2599-2609